General
Preferred name
AMSACRINE
Synonyms
AMSACRINE HYDROCHLORIDE ()
acridinyl anisidide hydrochloride ()
m-AMSA hydrochloride ()
AMSA ()
m-AMSA ()
CI-880 ()
acridinyl anisidide ()
amsacrine, Bristol-Myers ()
Amsacrine (hydrochloride) ()
m-AMSA, acridinyl anisidide ()
NSC-249992 ()
NSC-156303 ()
Amsidyl ()
SN-11841 ()
Amsidine ()
NCI-249992 ()
Amekrin ()
Amsidil ()
Acridinylanisidide ()
SN-21429 ()
Lamasine ()
Amsacrina ()
P&D ID
PD001019
CAS
54301-15-4
51264-14-3
Tags
available
drug
nuisance
First approval
1987
Drug indication
Acute lymphoblastic leukaemia
Neoplasm
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Amsacrine (m-AMSA; acridinyl anisidide) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
PRICE
32
DESCRIPTION
Amsacrine hydrochloride (m-AMSA hydrochloride; acridinyl anisidide hydrochloride) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
PRICE
32
DESCRIPTION
Amsacrine is an antineoplastic agent which can intercalate into the DNA of tumor cells. It also expresses topoisomerase inhibitor activity, specifically inhibiting topoisomerase II.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Amsacrine (AMSA) (mAMSA) an antineoplastic agent which can intercalate into the DNA of tumor cells. Amsacrine also expresses topoisomerase inhibitor activity, specifically inhibiting topoisomerase II.
(TargetMol Bioactive Compound Library)
DESCRIPTION
DNA topoisomerase II inhibitor
(LOPAC library)
DESCRIPTION
Amsacrine hydrochloride is an antineoplastic agent which can intercalate into the DNA of tumor cells. It also expresses topoisomerase inhibitor activity, specifically inhibiting topoisomerase II.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Amsacrine hydrochloride (acridinyl anisidide hydrochloride) is topoisomerase II inhibitor , is used in the treatment of acute myelogenous leukemia.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
55
Organisms
3
Compound Sets
26
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
NIH Mechanistic Set
NPC Screening Collection
Nuisance compounds in cellular assays
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
66
Molecular Weight
393.11
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
4
cLogP
4.51
TPSA
80.32
Fraction CSP3
0.1
Chiral centers
0.0
Largest ring
6.0
QED
0.49
Structural alerts
2
amino_acridine_A(46)
c:1:c:2:c(:c:c:c:1):n:c:3:c(:c:2-[#7]):c:c:c:c:3
PAINS Family B
Intercalation
Nuisance compounds
Custom attributes
(extracted from source data)
Selectivity
TopoII
Pathway
Autophagy
DNA Damage/DNA Repair
Membrane Transporter/Ion Channel
Cell Cycle/DNA Damage
Target
KCNH2, TOP2A
Topoisomerase
Potassium Channel
Topo II
Indication
acute lymphoblastic leukemia (ALL)
MOA
Topoisomerase inhibitor
Therapeutic Class
Anticancer Agents
Source data

